Læknaneminn - 01.10.1996, Qupperneq 64

Helicobacter pylori - yfirlitsgrein
77. Hallgrímur Guðjónsson, Herdís Ástráðsdóttir, Bjarni Þjóðleifsson:
Árangur þriggja lyfja meðferðar gegn Helicobacter pylori hjá sjúk-
lingum með skeifugarnarsár. Læknablaðið 1995, 81: 303-307
78. Ragna Leifsdóttir, Kjartan Örvar, Sigrún Sæmundsdóttir, Ásgeir
Theódórs: Uppræting á Helicobacter pylori: Langtímaeftirlit.
Læknablaðið 1996, 82/fylgirit 31:27-28,
79. Hjalti Már Björnsson, Kjartan örvar, Ásgeir Theodórs: Helic-
obacter pylori: samanburður á 7 og 14 daga meðferð. Læknablaðið
1996, 82/fylgirit 31:28-29, Scand J Gastroenterol 1996, 31/Suppl
217:25.
80. de Boer WA, Driessen WM, Jansz AR, Tytgat GNJ: Effect of acid
suppression on efficacy of treatment for Helicobacter pylori infect-
ion. Lancet 1995, 345:817-820
81. de Boer WA, Driessen WM, Potters VP, Tytgat GN: Randomized
study comparing 1 with 2 weeks of quadruple therapy for eradicat-
ing Helicobacter pylori. European Journal of Gastroenterology
1994. 89(11): 1993-1997
82. Sherman P, Shames B, Loo V, Matlow A, Drumm B, Penner J:
Omeprazole therapy for Helicobacter pylori infection. Scand J
Gastroenterol 1992, 27:1014-1022
83. Hosking SW, Ling TK, Yung MY, Cheng A, Chung SC, Leung Jw,
Li AK: Randomised controlled trial of short term treatment to era-
dicate Helicobacter pylori in patients with duodenal ulcer. BMJ
1992, 305(6852):502-504
84. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Roda A, Roda E et al:
Efficacy and tolerability of a short-term, low dose triple therapy for
eradication of Helicobacter pylori. Gastroenterology 1993. 104:A40
85. Jaup BH, Norrby A: Low dose,short-term triple therapy for cure of
Helicobacter pylori infection and healing of peptic ulcers. Am J
Gastroenterol 1995. 90:943-945
86. Moayyedi P, Axon ATR: Efficacy of a new one week triple regime
in eradicating Helicobacter pylori. Gut 1994. 35:F248
87. LindT, Veldhuyzen van Zanten SJO, Unge P, Spiller RC, Bayerdörf-
fer E, O'Morain C et al: The MACH 1 study: optimal 1-week tr-
eatment for H. pylori. Gut 1995; 37(suppl l.):A15
88. Tucci A, Corinaldesi R, Stanghellini V, et al: One-day therapy for
treatment of Helicobacter pylori infection. Dig Dis Sci 1993,
38:1670-1673
89. Kimura K, Ido K, Saifuku K, Taniguchi Y, Kihira K, Satoh K,
Takimoto T, Yoshida Y: A 1-h topical therapy for the treatment of
Helicobacter pylori infection. Am J Gastroenterol 1995, 90(1):60-
63
90. European Study Group on antibiotic susceptibility of Helicobacter
pylori: Results of a multicentre European survey in 1991of metron-
idazole resistance in Helicobacter pylori. Eur J Clin Microbol Infect
Dis 1992. 11:777-781
91. Sellman S, BlanchardTG, Nedrud JG, Czinn SJ: Vaccine strategies
for prevention of Helicobacter pylori infection. Eur J Gastroenter-
ol Hepatol 1995 7 Suppl l:Sl-6
92. Lee CK, Weltzin R, Thomas WD Jr, Kleanthous H, Ermak TH,
Soman G, Hill JE, Ackerman SK, Monath TP: Oral immunization
with recombinant Helicobacter pylori urease induces secretory IgA
antibodies and protects mice from challenge with Helicobacter fel-
is. J Inf Dis 1995, 172(1): 161-172
93. Corthesy-Theulaz I, Porta N, Glauser M, Saraga E, Vaney AC, Haas
R, Kraehenbuhl JP, Blum AL, Michetti P: Oral immunization with
Helicobacter pylori urease B subunit as a treatment against Helic-
obacter infection in mice. Gastroenterology 1995, 109(1): 115-121
LÆKNANEMINN
54
2. tbl. 1996, 49. árg.